BioPharma Pharma Research

Australia Grants AUD 17M to TB Alliance for Innovative Treatments

The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Allia...

 March 25, 2024 | News

Lynk Pharmaceuticals Initiates Pivotal Phase III Trial for Groundbreaking Atopic Dermatitis Treatment

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced that it...

 March 22, 2024 | News

Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,

Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...

 March 21, 2024 | News

Thailand Welcomes Groundbreaking NanoString Center for Excellence in Genomic Research

NanoString Center for Excellence (COE) has officially opened its doors in Thailand, thanks to a pioneering partnership with Prima Scientific Co., Ltd. This...

 March 19, 2024 | News

BioGeometry and Sanyou Bio Announce Pioneering Alliance to Accelerate AI-Powered Antibody Research

BioGeometry, a frontrunner in digital biology and AI-driven protein design, alongside Sanyou Bio, a leading force in the high-tech biotechnology sector, ha...

 March 19, 2024 | News

FDA Grants Fast Track Designation to ImmVira's MVR-T3011 IT for Advanced Head and Neck Cancer

ImmVira's groundbreaking oncolytic virus therapy, MVR-T3011 IT intratumoral injection, has been awarded Fast Track designation by the U.S. Food and Drug Ad...

 March 18, 2024 | News

ProteoNic Biosciences and Ginkgo Bioworks Forge Strategic Partnership to Enhance Biologics Production

 ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, announced a partnership with&nbs...

 March 15, 2024 | News

Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013

Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...

 March 14, 2024 | News

Cellectricon launches new Neuroinflammation Research Service

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Establish...

 March 13, 2024 | News

Sanyou Biopharmaceuticals Launches Groundbreaking Intelligent Innovative Biologics R&D Service Platform

Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," ...

 March 13, 2024 | News

Metabolon and Cardiff University Join Forces to Advance Multiple Sclerosis Research

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

 March 13, 2024 | News

Ono Pharmaceutical Forms Strategic Alliance with Harvard University for Drug Discovery

 Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...

 March 12, 2024 | News

Eli Lilly Reveals Promising Phase 3 Results for Lebrikizumab in Patients with Skin of Color

Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color...

 March 11, 2024 | News

Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China

  “Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...

 February 28, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in